Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders

We characterized the genetic architecture of the attention-deficit hyperactivity disorder-substance use disorder (ADHD-SUD) relationship by investigating genetic correlation, causality, pleiotropy, and common polygenic risk. Summary statistics from genome-wide association studies (GWAS) were used to investigate ADHD (N(eff) = 51,568), cannabis use disorder (CanUD, N(eff) = 161,053), opioid use disorder (OUD, N(eff) = 57,120), problematic alcohol use (PAU, N(eff) = 502,272), and problematic…

via https://pubmed.ncbi.nlm.nih.gov/38335780/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=None&utm_content=1lqZ3NPYysePVKsoyz66mDSgu4veDGJwnUBS47TBQPoOuNZY5J&fc=None&ff=20240222011009&v=2.18.0.post9+e462414